Holen Sie sich die Stockscreener-App
1.04
3.96%
0.03
Schlusskurs vom Vortag:
$1.01
Offen:
$1
24-Stunden-Volumen:
101.83K
Relative Volume:
0.48
Marktkapitalisierung:
$18.10M
Einnahmen:
$52.68M
Nettoeinkommen (Verlust:
$-4.44M
KGV:
-3.9514
EPS:
-0.2632
Netto-Cashflow:
$-2.26M
1W Leistung:
+0.00%
1M Leistung:
-0.94%
6M Leistung:
+10.51%
1J Leistung:
+7.14%
1-Tages-Spanne:
$0.98
$1.045
1-Wochen-Bereich:
$0.98
$1.0418
52-Wochen-Spanne:
$0.8688
$1.6481
Iridex Corp Stock (IRIX) Company Profile
Firmenname
Iridex Corp
Sektor
Branche
Telefon
(650) 940-4700
Adresse
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Compare IRIX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.04 | 17.58M | 52.68M | -4.44M | -2.26M | -0.2632 |
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2017-11-03 | Fortgesetzt | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2016-01-26 | Eingeleitet | Singular Research | Buy |
| 2007-01-03 | Eingeleitet | First Albany | Buy |
Iridex Corp Aktie (IRIX) Neueste Nachrichten
Iridex CFO Romeo Dizon buys $5,004 in company stock - Investing.com
IRIDEX Corp (IRIX) CFO adds 5,004 common shares in open-market buy - Stock Titan
IRIDEX Trades Around $1 Following Holiday, Eye-Care Firm Faces Next Challenges - Bez Kabli
IRIX Stock Up 4% As Q1 Loss Narrows Y/Y on Glaucoma Product Growth - Yahoo Finance
IRIDEX Corporation (IRIX) Q1 2026 Earnings Surge: EPS $-0.03 vs $-0.07 ForecastGross Profit Margin - Newser
IRIDEX Corporation (NASDAQ:IRIX) Q1 2026 Earnings Call Transcript - Insider Monkey
IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic Growth Initiatives - GuruFocus
IRIDEX Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Iridex Beats Profit Forecasts on Cost Cuts Amidst Revenue Dip - BriefGlance
Iridex Q1 2026 Earnings Call: Complete Transcript - Benzinga
IRIDEX earnings beat by $0.02, revenue fell short of estimates - Investing.com
IRIDEX Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Is IRIDEX (IRIX) a Value Trap After Q1 2026? EPS -$0.03 Beats (e - GuruFocus
Iridex Corp (NASDAQ:IRIX) Q1 Loss Narrower Than Expected, Glaucoma Portfolio Strengthens - ChartMill
Iridex posts narrower-than-feared Q1 loss driven by cost cuts; Shares up 4% - Investing.com South Africa
Iridex Reports Q1 2026: Revenue $11.8M, Gross Profit $4.7M, Net Loss $0.5M - TradingView
IRIDEX CORP 1Q 2026: Revenue $11.8M, EPS $(0.03) — 10-Q Summary - TradingView
IRIDEX (NASDAQ: IRIX) narrows quarterly loss as margins tighten - Stock Titan
Iridex (NASDAQ: IRIX) Q1 loss narrows as 2026 outlook reaffirmed - Stock Titan
Iridex: Q1 Earnings Snapshot - marketscreener.com
Iridex Reports First Quarter 2026 Financial Results - Yahoo Finance
IRIDEX Corp stock (US4627191006): eye-care specialist draws attention after FDA clearance and strate - AD HOC NEWS
IRIDEX Corp (IRIX) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada
IRIDEX Corp expected to post a loss of 7 cents a shareEarnings Preview - TradingView
IRIDEX Corp stock (US4627191006): Ophthalmology device maker with recent market activity - AD HOC NEWS
Earnings Preview: IRIDEX to Report Financial Results Post-market on May 19 - Moomoo
IRIDEX Corp stock (US4627191006): Recent 1.94% gain on Nasdaq - AD HOC NEWS
MSN Money - MSN
The shareholder friendly policies at IRIDEX Corporation (IRIX) | Q4 2025: EPS Beats ForecastsPro Level Trade Signals - Newser
What IRIDEX Corporation (IRIX) does that makes it resilient (Breakdown Watch) 2026-05-07Rounding Top - Newser
Iridex to Report First Quarter 2026 Financial Results on May 19, 2026 - The Manila Times
Iridex sets May 19 investor call with Q1 results after close - Stock Titan
Iridex (NASDAQ: IRIX) schedules 2026 meeting on board, pay, auditor - Stock Titan
[ARS] IRIDEX CORP SEC Filing - Stock Titan
IRIDEX Corporation (IRIX) Stock: What Affects Its Direction | Q4 2025: Profit SurprisesShort Interest - Cổng thông tin điện tử Tỉnh Sơn La
The Zacks Analyst Blog Microsoft, AbbVie, BHP, CBL & Associates Properties and IRIDEX - Zacks Investment Research
IRIDEX Corporation (IRIX) Stock Cash Trade (Breakout Watch) 2026-04-18Earnings Season - newser.com
IRIDEX Corporation (IRIX) Stock Outlook | Q4 2025: EPS Tops ViewsCatalyst Event - newser.com
Aug Reactions: Is IRIDEX Corporation forming a double bottomGDP Growth & Weekly High Return Stock Forecasts - baoquankhu1.vn
Should I Buy IRIDEX Corporation (IRIX) Stock in 2026 | Price at $1.01, Down 1.94%Small Cap Breakout - newser.com
Iridex Announces New Partnership with EyeProGPO to Expand Member Access to Retina Laser Technology - The Manila Times
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Wondering what's happening in today's after-hours session? - ChartMill
Iridex partners with EyeProGPO for retina laser distribution - Investing.com
More than 1,800 eye care members gain pricing access to Iridex lasers - Stock Titan
IRIX Should I Buy - Intellectia AI
IRIX.O Technical Analysis & Stock Price Forecast - Intellectia AI
IRIX.O PE Ratio & Valuation, Is IRIX.O Overvalued - Intellectia AI
IRIDEX Corporation: Innovative Ophthalmic Laser Solutions for Glaucoma and Retinal Diseases - Minichart
IRIDEX (NASDAQ: IRIX) 10% holder gets interest paid in stock - Stock Titan
Iridex 10-K: Revenue $52.7M, EPS $(0.26) - TradingView — Track All Markets
Finanzdaten der Iridex Corp-Aktie (IRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Iridex Corp-Aktie (IRIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer |
Feb 17 '26 |
Buy |
1.34 |
2,200 |
2,942 |
119,890 |
| Dizon Romeo R | Chief Financial Officer |
Feb 12 '26 |
Buy |
1.43 |
1,500 |
2,145 |
117,690 |
| Dizon Romeo R | Chief Financial Officer |
Feb 10 '26 |
Buy |
1.46 |
1,000 |
1,460 |
116,190 |
| Dizon Romeo R | Chief Financial Officer |
Feb 03 '26 |
Buy |
1.38 |
2,500 |
3,450 |
115,190 |
| Dizon Romeo R | Chief Financial Officer |
Jan 29 '26 |
Buy |
1.44 |
1,101 |
1,588 |
112,690 |
| Dizon Romeo R | Chief Financial Officer |
Jan 28 '26 |
Buy |
1.46 |
1,300 |
1,898 |
111,589 |
| Dizon Romeo R | Chief Financial Officer |
Jan 27 '26 |
Buy |
1.48 |
3,385 |
5,009 |
110,289 |
| Dizon Romeo R | Chief Financial Officer |
Jan 26 '26 |
Buy |
1.52 |
1,243 |
1,889 |
106,904 |
| Dizon Romeo R | Chief Financial Officer |
Jan 23 '26 |
Buy |
1.48 |
5,221 |
7,716 |
105,661 |
| Dizon Romeo R | Chief Financial Officer |
Jan 21 '26 |
Buy |
1.50 |
2,159 |
3,233 |
100,440 |
1.35%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):